Get the Stockscreener App
2.24
1.82%
0.04
After Hours:
2.24
Collplant Biotechnologies Ltd stock is traded at $2.24, with a volume of 14,249.
It is up +1.82% in the last 24 hours and down -14.50% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$2.20
Open:
$2.1
24h Volume:
14,249
Relative Volume:
0.13
Market Cap:
$28.48M
Revenue:
$2.47M
Net Income/Loss:
$-13.87M
P/E Ratio:
-1.8361
EPS:
-1.22
Net Cash Flow:
$-12.42M
1W Performance:
-5.88%
1M Performance:
-14.50%
6M Performance:
-8.11%
1Y Performance:
-51.99%
1-Day Range:
$2.09
$2.275
1-Week Range:
$2.09
$2.4426
52-Week Range:
$1.31
$4.99
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.24 | 27.98M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
Strategies to average down on CollPlant Biotechnologies Ltd.2025 Pullback Review & Expert Curated Trade Ideas - newser.com
Published on: 2025-10-13 10:29:10 - newser.com
Is CollPlant Biotechnologies Ltd. stock dividend yield sustainableJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
How CollPlant Biotechnologies Ltd. stock benefits from tech adoptionJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
What drives CollPlant Biotechnologies Ltd CPT stock priceEnergy Sector Updates & Rapid Capital Gain - earlytimes.in
Visualizing CollPlant Biotechnologies Ltd. stock with heatmapsEarnings Growth Summary & Short-Term High Return Strategies - newser.com
CollPlant Biotechnologies Ltd. stock prediction for this weekJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Analyzing CollPlant Biotechnologies Ltd. with multi timeframe chartsQuarterly Growth Report & Capital Efficient Trade Techniques - newser.com
CollPlant Biotechnologies (NASDAQ:CLGN) Trading Down 7.6% – What’s Next? - Defense World
CollPlant Biotechnologies Ltd CPT Stock Analysis and ForecastMerger & Acquisition Updates & Market Trend Real-Time Reports - earlytimes.in
Historical volatility pattern of CollPlant Biotechnologies Ltd. visualized2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Why CollPlant Biotechnologies Ltd. stock is trending among retail traders2025 Big Picture & Verified Entry Point Signals - newser.com
Quantitative breakdown of CollPlant Biotechnologies Ltd. recent moveTrend Reversal & Safe Entry Momentum Tips - newser.com
Multi factor analysis applied to CollPlant Biotechnologies Ltd.Earnings Summary Report & Entry Point Confirmation Alerts - newser.com
Tools to assess CollPlant Biotechnologies Ltd.’s risk profileWeekly Stock Summary & Community Driven Trade Alerts - newser.com
How to manage a losing position in CollPlant Biotechnologies Ltd.Weekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year - Yahoo Finance
Comparing CollPlant Biotechnologies Ltd. in custom built stock radarsWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Using data filters to optimize entry into CollPlant Biotechnologies Ltd.Portfolio Performance Summary & Community Trade Idea Sharing - newser.com
Collplant stock plunges after advancing dermal filler to clinical trials By Investing.com - Investing.com Nigeria
Collplant stock plunges after advancing dermal filler to clinical trials - Investing.com
CollPlant advances photocurable dermal filler to clinical trials By Investing.com - Investing.com Australia
CollPlant advances photocurable dermal filler to clinical trials - Investing.com India
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - MarketScreener
United States 3D Printed Organ Market Set to Transform - openPR.com
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):